MAM
QTTB icon

Martingale Asset Management’s Q32 Bio QTTB Stock Holding History

Martingale Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-851
Closed -$122K – 905
2021
Q3 		$122K Buy
+851
New +$108K ﹤0.01% 835
2021
Q2 		– Sell
-995
Closed -$170K – 906
2021
Q1 		$170K Hold
995
– – ﹤0.01% 826
2020
Q4 		$204K Sell
995
-4,328
-81% -$837K ﹤0.01% 835
2020
Q3 		$1.03M Sell
5,323
-2,728
-34% -$611K 0.01% 631
2020
Q2 		$2.2M Buy
+8,051
New +$2.15M 0.03% 496

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Martingale Asset Management's QTTB Position: Q4 2021 in Review

Martingale Asset Management sold out of Q32 Bio (QTTB) in Q4 2021, closing a stake of 851 shares — an estimated $122K sold.

Martingale Asset Management first reported a position in QTTB in Q2 2020 and held it in 5 quarters. The position peaked at $2.2M in Q2 2020. 120 funds tracked by Wall St. Rank hold QTTB as of Q4 2021.

  • Martingale Asset Management reported no remaining Q32 Bio position as of Q4 2021 after selling out during the quarter.
  • Martingale Asset Management sold 851 Q32 Bio shares in Q4 2021, an estimated $122K.
  • Martingale Asset Management first reported a position in Q32 Bio in Q2 2020 and held it in 5 quarters.
  • Martingale Asset Management's Q32 Bio position peaked at $2.2M in Q2 2020.
  • 120 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2021.

Based on Martingale Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.